These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34224815)
1. Biliverdin reductase as a target in drug research and development: Facts and hypotheses. Mancuso C Free Radic Biol Med; 2021 Aug; 172():521-529. PubMed ID: 34224815 [TBL] [Abstract][Full Text] [Related]
2. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166 [TBL] [Abstract][Full Text] [Related]
3. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037 [TBL] [Abstract][Full Text] [Related]
4. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164 [TBL] [Abstract][Full Text] [Related]
5. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Florczyk UM; Jozkowicz A; Dulak J Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984 [TBL] [Abstract][Full Text] [Related]
6. Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings. Maines MD Curr Drug Targets; 2010 Dec; 11(12):1586-94. PubMed ID: 20704544 [TBL] [Abstract][Full Text] [Related]
8. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Lerner-Marmarosh N; Shen J; Torno MD; Kravets A; Hu Z; Maines MD Proc Natl Acad Sci U S A; 2005 May; 102(20):7109-14. PubMed ID: 15870194 [TBL] [Abstract][Full Text] [Related]
10. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094 [TBL] [Abstract][Full Text] [Related]
11. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Barone E; Di Domenico F; Mancuso C; Butterfield DA Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978 [TBL] [Abstract][Full Text] [Related]
12. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142 [TBL] [Abstract][Full Text] [Related]
13. Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Pereira PJ; Macedo-Ribeiro S; Párraga A; Pérez-Luque R; Cunningham O; Darcy K; Mantle TJ; Coll M Nat Struct Biol; 2001 Mar; 8(3):215-20. PubMed ID: 11224564 [TBL] [Abstract][Full Text] [Related]
14. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity. Cimini FA; Arena A; Barchetta I; Tramutola A; Ceccarelli V; Lanzillotta C; Fontana M; Bertoccini L; Leonetti F; Capoccia D; Silecchia G; Di Cristofano C; Chiappetta C; Di Domenico F; Baroni MG; Perluigi M; Cavallo MG; Barone E Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1490-1501. PubMed ID: 30826467 [TBL] [Abstract][Full Text] [Related]
15. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation. Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089 [TBL] [Abstract][Full Text] [Related]
16. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development. Mancuso C Expert Opin Ther Targets; 2022 Apr; 26(4):361-374. PubMed ID: 35285395 [TBL] [Abstract][Full Text] [Related]
17. Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Barone E; Mancuso C; Di Domenico F; Sultana R; Murphy MP; Head E; Butterfield DA J Neurochem; 2012 Jan; 120(1):135-46. PubMed ID: 22004509 [TBL] [Abstract][Full Text] [Related]
18. Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Barone E; Di Domenico F; Cassano T; Arena A; Tramutola A; Lavecchia MA; Coccia R; Butterfield DA; Perluigi M Free Radic Biol Med; 2016 Feb; 91():127-42. PubMed ID: 26698666 [TBL] [Abstract][Full Text] [Related]